Ian Crocker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ian Crocker has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hui-Kuo George Shu
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
2 shared publications - Roshan S. Prabhu
Emory University
2 shared publications - Walter J. Curran
Department of Radiation Oncology and Winship Cancer Institute, Emory University , Atlanta, GA , USA
2 shared publications - Arif N. Ali
The Hope Center accruals Emory University/Winship Cancer Institute, Dalton, GA
1 shared publication - Bree Ruppert Eaton
Department of Radiation Oncology, Emory University, Atlanta, GA 30322, USA
1 shared publication - Brent Hayek
Division of Oculoplastics, Orbital and Cosmetic Surgery, Emory University, Atlanta, Georgia, USA
1 shared publication
Latest Publications
- Open Access
- 10 January 2014
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 20
Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme
To dosimetrically evaluate the effect of reduced margin radiotherapy on hippocampal dose for glioblastoma multiforme (GBM) patients. GBM patients enrolled on the Radiation Therapy Oncology Group (RTOG) 0825 trial at our institution were identified. Standard RTOG 0825 expansions were 2 cm + 3-5 mm from the gross tumor volume (GTV) to the clinical tumor volume (CTV) and from the CTV to the planning tumor volume (PTV), respectively. These same patients also had reduced margin tumor volumes generated with 8 mm (GTV to CTV) + 3 mm (CTV to PTV) expansions. Individual plans were created for both standard and reduced margin structures. The dose-volume histograms were statistically compared with a paired, two-tailed Student's t-test with a significance level of p < 0.05. A total of 16 patients were enrolled on RTOG 0825. The reduced margins resulted in statistically significant reductions in hippocampal dose at all evaluated endpoints. The hippocampal Dmax was reduced from a mean of 61.4 Gy to 56.1 Gy (8.7%), D40% was reduced from 49.9 Gy to 36.5 Gy (26.9%), D60% was reduced from 32.7 Gy to 18.7 Gy (42.9%) and the D80% was reduced from 27.3 Gy to 15.3 Gy (44%). The use of reduced margin PTV expansions in the treatment of GBM patients results in significant reductions in hippocampal dose. Though the exact clinical benefit of this reduction is currently unclear, this study does provide support for a future prospective trial evaluating the neurocognitive benefits of reduced margin tumor volumes in the treatment of GBM patients.
- 10 January 2014
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 20
Open AccessImproved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme
To dosimetrically evaluate the effect of reduced margin radiotherapy on hippocampal dose for glioblastoma multiforme (GBM) patients. GBM patients enrolled on the Radiation Therapy Oncology Group (RTOG) 0825 trial at our institution were identified. Standard RTOG 0825 expansions were 2 cm + 3-5 mm from the gross tumor volume (GTV) to the clinical tumor volume (CTV) and from the CTV to the planning tumor volume (PTV), respectively. These same patients also had reduced margin tumor volumes generated with 8 mm (GTV to CTV) + 3 mm (CTV to PTV) expansions. Individual plans were created for both standard and reduced margin structures. The dose-volume histograms were statistically compared with a paired, two-tailed Student's t-test with a significance level of p < 0.05. A total of 16 patients were enrolled on RTOG 0825. The reduced margins resulted in statistically significant reductions in hippocampal dose at all evaluated endpoints. The hippocampal Dmax was reduced from a mean of 61.4 Gy to 56.1 Gy (8.7%), D40% was reduced from 49.9 Gy to 36.5 Gy (26.9%), D60% was reduced from 32.7 Gy to 18.7 Gy (42.9%) and the D80% was reduced from 27.3 Gy to 15.3 Gy (44%). The use of reduced margin PTV expansions in the treatment of GBM patients results in significant reductions in hippocampal dose. Though the exact clinical benefit of this reduction is currently unclear, this study does provide support for a future prospective trial evaluating the neurocognitive benefits of reduced margin tumor volumes in the treatment of GBM patients.
- Open Access
- 7 June 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 135
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Hypofractionated Radiosurgery (HR) is a therapeutic option for delivering partial brain radiotherapy (RT) to large brain metastases or resection cavities otherwise not amenable to single fraction radiosurgery (SRS). The use, safety and efficacy of HR for brain metastases is not well characterized and the optimal RT dose-fractionation schedule is undefined.
- 7 June 2013
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 135
Open AccessHypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Hypofractionated Radiosurgery (HR) is a therapeutic option for delivering partial brain radiotherapy (RT) to large brain metastases or resection cavities otherwise not amenable to single fraction radiosurgery (SRS). The use, safety and efficacy of HR for brain metastases is not well characterized and the optimal RT dose-fractionation schedule is undefined.
- Open Access
- 19 June 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 95
Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
The optimal initial local treatment for patients with Graves’ ophthalmopathy (GO) is not fully characterized. The purpose of this retrospective study is to describe the clinical outcomes of RT as initial local therapy for GO and define predictors of the need for post-RT salvage bony decompressive surgery.
- 19 June 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 95
Open AccessClinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
The optimal initial local treatment for patients with Graves’ ophthalmopathy (GO) is not fully characterized. The purpose of this retrospective study is to describe the clinical outcomes of RT as initial local therapy for GO and define predictors of the need for post-RT salvage bony decompressive surgery.